company background image
OFIX

Orthofix Medical NasdaqGS:OFIX Stock Report

Last Price

US$28.47

Market Cap

US$549.2m

7D

6.7%

1Y

-30.4%

Updated

17 May, 2022

Data

Company Financials +
OFIX fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends0/6

OFIX Stock Overview

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally.

Rewards

Earnings are forecast to grow 74.31% per year

Risk Analysis

No risks detected for OFIX from our risk checks.

Orthofix Medical Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Orthofix Medical
Historical stock prices
Current Share PriceUS$28.47
52 Week HighUS$43.30
52 Week LowUS$26.13
Beta0.96
1 Month Change-12.08%
3 Month Change-14.01%
1 Year Change-30.43%
3 Year Change-44.51%
5 Year Change-33.11%
Change since IPO171.14%

Recent News & Updates

May 12
Estimating The Fair Value Of Orthofix Medical Inc. (NASDAQ:OFIX)

Estimating The Fair Value Of Orthofix Medical Inc. (NASDAQ:OFIX)

How far off is Orthofix Medical Inc. ( NASDAQ:OFIX ) from its intrinsic value? Using the most recent financial data...

Apr 21
Companies Like Orthofix Medical (NASDAQ:OFIX) Can Afford To Invest In Growth

Companies Like Orthofix Medical (NASDAQ:OFIX) Can Afford To Invest In Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Shareholder Returns

OFIXUS Medical EquipmentUS Market
7D6.7%5.7%2.7%
1Y-30.4%-13.0%-8.1%

Return vs Industry: OFIX underperformed the US Medical Equipment industry which returned -15.1% over the past year.

Return vs Market: OFIX underperformed the US Market which returned -10.8% over the past year.

Price Volatility

Is OFIX's price volatile compared to industry and market?
OFIX volatility
OFIX Average Weekly Movement5.5%
Medical Equipment Industry Average Movement10.6%
Market Average Movement7.8%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market2.9%

Stable Share Price: OFIX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: OFIX's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19801,087Jon Serbousekhttps://www.orthofix.com

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures.

Orthofix Medical Fundamentals Summary

How do Orthofix Medical's earnings and revenue compare to its market cap?
OFIX fundamental statistics
Market CapUS$549.17m
Earnings (TTM)-US$37.02m
Revenue (TTM)US$465.30m

1.2x

P/S Ratio

-15.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
OFIX income statement (TTM)
RevenueUS$465.30m
Cost of RevenueUS$117.32m
Gross ProfitUS$347.99m
Other ExpensesUS$385.01m
Earnings-US$37.02m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.86
Gross Margin74.79%
Net Profit Margin-7.96%
Debt/Equity Ratio0%

How did OFIX perform over the long term?

See historical performance and comparison

Valuation

Is Orthofix Medical undervalued compared to its fair value and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


1.69x

Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: OFIX ($28.47) is trading above our estimate of fair value ($23.93)

Significantly Below Fair Value: OFIX is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: OFIX is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: OFIX is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate OFIX's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: OFIX is good value based on its PB Ratio (1.7x) compared to the US Medical Equipment industry average (2.5x).


Future Growth

How is Orthofix Medical forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


74.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: OFIX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: OFIX is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: OFIX's is expected to become profitable in the next 3 years.

Revenue vs Market: OFIX's revenue (5.9% per year) is forecast to grow slower than the US market (7.9% per year).

High Growth Revenue: OFIX's revenue (5.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OFIX's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Orthofix Medical performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-47.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: OFIX is currently unprofitable.

Growing Profit Margin: OFIX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: OFIX is unprofitable, and losses have increased over the past 5 years at a rate of 47.2% per year.

Accelerating Growth: Unable to compare OFIX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OFIX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.7%).


Return on Equity

High ROE: OFIX has a negative Return on Equity (-11.03%), as it is currently unprofitable.


Financial Health

How is Orthofix Medical's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: OFIX's short term assets ($255.1M) exceed its short term liabilities ($88.2M).

Long Term Liabilities: OFIX's short term assets ($255.1M) exceed its long term liabilities ($38.2M).


Debt to Equity History and Analysis

Debt Level: OFIX is debt free.

Reducing Debt: OFIX had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OFIX has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if OFIX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Orthofix Medical current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate OFIX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate OFIX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if OFIX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OFIX's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as OFIX has not reported any payouts.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average management tenure


CEO

Jon Serbousek (60 yo)

2.5yrs

Tenure

US$5,340,865

Compensation

Mr. Jon C. Serbousek had been the Chairman of the Board at Vesselon, Inc. since February 26, 2015 and served as its Director. He has been a Board Member at ArthroFree LLC. He has been President, Chief Exec...


CEO Compensation Analysis

Compensation vs Market: Jon's total compensation ($USD5.34M) is above average for companies of similar size in the US market ($USD2.62M).

Compensation vs Earnings: Jon's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: OFIX's management team is considered experienced (4.3 years average tenure).


Board Members

Experienced Board: OFIX's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Orthofix Medical Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Orthofix Medical Inc.
  • Ticker: OFIX
  • Exchange: NasdaqGS
  • Founded: 1980
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$549.172m
  • Shares outstanding: 19.91m
  • Website: https://www.orthofix.com

Number of Employees


Location

  • Orthofix Medical Inc.
  • 3451 Plano Parkway
  • Lewisville
  • Texas
  • 75056
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/17 00:00
End of Day Share Price2022/05/17 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.